Archive

Tag: Atrial Fibrillation

The EAST-AFNET 4 Trial: Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

Background: Approximately one in four adults over forty-five years of age will develop atrial fibrillation (AF) during their lifetime. There is a clear association between AF and premature death, ischemic stroke, and cardiovascular events in the first year after atrial …

Read More
Cardiovascular

RAFF2: Electrical vs Pharmacological Cardioversion for ED Patients with Acute Atrial Fibrillation

Background: Acute atrial fibrillation (AF) is one of the most common dysrhythmias seen in the emergency department (ED). There has been extensive discussion and debate about the best way to manage acute AF centered around rate and rhythm control.  However, …

Read More
Cardiovascular

Comparison of Chemical vs Electrical Cardioversion of Acute Uncomplicated Atrial Fibrillation

Background Information: Atrial fibrillation is the most commonly encountered dysrhythmia in the emergency department (ED) and is associated with an increased long-term risk of stroke, heart-failure and all-cause mortality.1,2 In fact, the overall mortality rate for patients with atrial fibrillation is …

Read More
Cardiovascular

AFib: Wait-and-See or Early Cardioversion to Obtain Normal Sinus Rhythm?

Background: Atrial fibrillation (AF) is a common cardiac dysrhythmia encountered in the emergency department (ED), affecting 2.7 million – 6.1 million Americans annually. Hospitalizations with AF as the primary diagnosis total >467,000 annually. AF is associated with a 5-fold increased risk …

Read More
Cardiovascular

LOMAGHI Trial: Magnesium Sulfate for Rapid Atrial Fibrillation?

Background: Currently, several medications are recommended for the management of atrial fibrillation with rapid ventricular response in the emergency department including calcium channel blockers, beta blockers and digoxin (the optimal choice is still up for debate). Magnesium sulfate may play a role …

Read More
Cardiovascular

Sponsored